-- EZchip Discount Narrows on Q2 Outlook: Israel Overnight
-- B y   J e s s i c a   S u m m e r s
-- 2013-07-17T08:01:39Z
-- http://www.bloomberg.com/news/2013-07-16/ezchip-discount-narrows-on-q2-outlook-israel-overnight.html
EZchip Semiconductor Ltd. (EZCH)  rose in
 New York , narrowing the Israeli chipmaker’s discount to Tel
Aviv-traded shares, on speculation that earnings growth will
pick up in the second half of the year.  The stock gained 0.3 percent to $27.72 in New York, leaving
it 1.6 percent below the price in Tel Aviv, where markets were
closed yesterday for a holiday.  Given (GIVN)  Imaging Ltd., the Israeli
maker of swallowable cameras, closed at a 4.4 percent  premium  in
New York. The Bloomberg Israel-US Equity Index retreated from
the highest close in almost two years, slipping 0.3 percent.  EZchip’s adjusted  profit  will more than double in the third
quarter and rise 30 percent in the last three months of the year
as customers ramp up orders for equipment that speeds up data
transfers, according to the average estimate of analysts
surveyed by Bloomberg.  Cisco Systems Inc. (CSCO) , the biggest maker of
networking equipment, reported profit that topped estimates in
its most recent quarter as businesses spent more to meet surging
demand for online data delivery.  “Their customers finally have some new products shipping,
and just the way the dynamics are, I think the second half is
setting up to be very good,” Andrew Uerkwitz, an analyst at
 Oppenheimer Holdings Inc. (OPY)  in New York, who rates EZchip the
equivalent of buy, said in a telephone interview yesterday.  The Bloomberg Israel-US gauge snapped a five-day rally,
dropping to 94.42. Israel’s benchmark  TA-25 Index (TA-25)  fell less than
0.1 percent to 1,220.10 at 10:56 a.m. in Tel Aviv. Israeli
markets were closed yesterday for the Tisha B’av fast day.  EZchip, based in Yokneam, Israel, this morning declined 0.9
percent to 99.45 shekels, or $27.81, in volume of 2.7 percent of
the three-month daily average. The company said yesterday that
it will report second-quarter earnings on Aug. 7.  Given rallied for a second day after the company announced
that its PillCam Colon was approved in  Japan  earlier than
estimated. The stock rose 0.2 percent to $15.51 in New York
yesterday, the highest price since May 21. The Yokneam, Israel-based company added 3.1 percent in  Tel Aviv  this morning to
54.55 shekels, or $15.26.  To contact the reporter on this story:
Jessica Summers in New York at 
 jsummers17@bloomberg.net   To contact the editor responsible for this story:
 Brendan Walsh  at 
 bwalsh8@bloomberg.net  